IP Library Granted Patent US 11,185,263
Granted Patent B2
US 11,185,263 · App. 16/198,363 · Granted Nov 30, 2021

Biosensor array for the detection of analytes

Inventors: Jeffrey LaBelle (Tempe, AZ); David Probst (Tempe, AZ); Bin Mu (Tempe, AZ)
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
A61B5/14865A61B5/14546A61B5/14735A61B5/145A61B5/1486A61B5/14503A61B5/14507G01N27/3271G01N27/3275G01N2333/62
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,185,263
App. No.
16/198,363
Granted
Nov 30, 2021
Kind
B2
Abstract

Embodiments of the present disclosure relate generally devices for detecting analytes in a subject. More particularly, the present disclosure provides a biosensor array for detecting analytes in a subject. Embodiments of the present disclosure include a biosensor array comprising a plurality of sensor cells for detecting an analyte in a subject. In accordance with these embodiments, the plurality of sensor cells comprise at least one electrode, at least one antibody immobilized on a surface of the at least one electrode, and a biodegradable coating in contact with the at least one antibody.

Claims (12)

1. An implantable biosensor for detecting insulin comprising:

an implantable biosensor array comprising a plurality of sensor cells comprising at least one working electrode, a counter electrode, and a reference electrode;

one or more insulin-specific antibodies immobilized on a surface of the at least one working electrode;

each sensor cell containing a biodegradable gelatin coating of varying thicknesses in direct contact with the one or more insulin-specific antibodies; and

where upon subcutaneous implantation in a subject, the various thicknesses of biodegradable gelatin coating degrade at different rates over a period of 1 week to 6 months thereby exposing the insulin-specific antibodies at varying time points.

2. The biosensor of claim 1 , wherein the biosensor array comprises at least 72 sensor cells.

3. The biosensor of claim 1 , wherein the biosensor array comprises 96 sensor cells.

4. The biosensor of claim 1 , wherein the biosensor array is about 0.1 mm-10 mm thick.

5. The biosensor of claim 1 , wherein the biosensor array is about 0.1 mm-5 mm thick.

6. A method for detecting insulin, the method comprising:

subcutaneously implanting the biosensor of claim 1 in a subject;

after the biodegradable gelatin coating degrades over the period of 1 week to 6 months exposing the insulin-specificantibody site, detecting insulin in the subject.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2019
From: LABELLE, JEFFREY; PROBST, DAVID; MU, BIN
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 049295/0917 →
Continuity (2)
Provisional Application 62589066 · Nov 21, 2017
Related Publication 20190150815A1 · May 23, 2019